We present here an analysis of the possible mechanisms for the effects of the “waking hormone” orexin on spatial learning, mediated by changes in the functioning of the hippocampus and structures connected to it. Published data indicate firstly that orexin can directly increase neuron excitation in different hippocampal fields, acting on Gq/11-protein-coupled postsynaptic OX1 and OX2 receptors. By facilitating the induction of long-term potentiation of excitatory transmission in each component of the trisynaptic pathway via the hippocampus, orexin can promote transmission of information through this structure and form neuronal reflections of “object-place” associations. Secondly, orexin can increase the release of acetylcholine, GABA, and glutamate in the hippocampus by potentiating excitation of neurons in the medial septum, which bear OX1 and OX2 receptors. This can result in changes in the extent and frequency of the hippocampal theta rhythm. Thirdly, orexin can affect the functional reinforcement circuit, which includes neurons in the hippocampus, prefrontal cortex, amygdala, ventral striatum, and ventral tegmental area, directly modulating their activity via OX receptors. Acting via increases in the activity of dopaminergic cells and increases in dopamine release, orexin can alter the nature of the functioning of the basal ganglia, improve the functioning of reinforcement circuits, and facilitate spatial learning.
Similar content being viewed by others
References
V. F. Kichigina, “Dopaminergic regulation of theta activity in septohippocampal neurons in awake rabbits,” Zh. Vyssh. Nerv. Deyat., 54, No. 2, 210–215 (2004).
V. F. Kichigina, “The mechanism of regulation and functional significance of the theta rhythm: the role of the serotoninergic and noradrenalinergic systems,” Zh. Vyssh. Nerv. Deyat., 54, No. 1, 101–119 (2004).
V. M. Koval’zon, Basic Somnology [in Russian], Binom, Moscow (2011).
I. G. Sil’kis, “Involvement of the trisynaptic hippocampal pathway in forming neuronal reflections of ‘object-place’ associations (an analytical review),” Zh. Vyssh. Nerv. Deyat., 59, No. 6, 645–661 (2009).
I. G. Sil’kis, “Mechanisms of the effects of dopamine via the basal ganglia on the septohippocampal theta rhythm,” Neirokhimiya, 25, No. 3, 184–190 (2008).
I. G. Sil’kis, “A unified postsynaptic mechanism for the influences of different neurotransmitters on the modification of excitatory and inhibitory inputs to hippocampal neurons (a hypothesis),” Usp. Fiziol. Nauk, 33, No. 1, 40–56 (2002).
I. G. Sil’kis, “A possible mechanism for the influences of neurotransmitters and modifiable inhibition on long-term potentiation and depression of the excitatory inputs to main neurons in the hippocampus,” Zh. Vyssh. Nerv. Deyat., 52, No. 4, 392–405 (2002).
A. Adamantidis and L. de Lecea, “Physiological arousal: a role for hypothalamic systems,” Cell Mol. Life Sci., 65, No. 10, 1475–1488 (2008).
E. Akbari, F. Motamedi, F. G. Davoodi, et al., “Orexin-1 receptor mediates long-term potentiation in the dentate gyrus area of freely moving rats,” Behav. Brain Res., 216, No. 1, 375–380 (2011).
E. Akbari, N. Naghdi, and F. Motamedi, “The selective orexin 1 receptor antagonist SB-334867-A impairs acquisition and consolidation but not retrieval of spatial memory in Morris water maze,” Peptides, 28, No. 3, 650–656 (2007).
E. Akbari, N. Naghdi, and F. Motamedi, “Functional inactivation of orexin 1 receptors in CA1 region impairs acquisition, consolidation and retrieval in Morris water maze task,” Behav. Brain Res., 173, No. 1, 47–52 (2006).
A. Alonso and C. Kohler, “A study of the reciprocal connections between the septum and the entorhinal area using anterograde and retrograde axonal transport methods in the rat brain,” J. Comp. Neurol., 225, No. 3, 327–343 (1984).
S. Aou, X. L. Li, A. J. Li, et al., “Orexin-A (hypocretin-I) impairs Morris water maze performance and CA1-Schaffer collateral longterm potentiation in rats,” Neurosci., 119, No. 4, 1221–1228 (2003).
S. Bastianni, A. Silvani, C. Berteotti, et al., “High-amplitude theta wave bursts during REM sleep and cataplexy in hypocretin-deficient narcoleptic mice,” J. Sleep Res., 21, No. 2, 185–188 (2011); 10.1111/j.1365-2869.2011.00945.x.
L. Bayer, E. Eggermann, M. Serafin, et al., “Opposite effects of noradrenaline and acetylcholine upon hypocretin/orexin versus melanin concentrating hormone neurons in rat hypothalamic slices,” Neurosci., 130, No. 4, 807–811 (2005).
L. Bayer, M. Serafin, E. Eggermann, et al., “Exclusive postsynaptic action of hypocretin-orexin on sublayer 6b cortical neurons,” J. Neurosci., 24, No. 30, 6760–6764 (2004).
B. H. Bland, S. Declerck, J. Jackson, et al., “Septohippocampal properties of N-methyl-D-aspartate-induced theta-band oscillation and synchrony,” Synapse, 61, No. 3, 185–(1997). (2007).
B. H. Bland and S. Oddie, “Anatomical, electrophysiological and pharmacological studies of ascending brainstem hippocampal synchronizing pathways,” Neurosci. Biobehav. Res., 22, No. 2, 259–273 (1998).
S. L. Borgland, E. Storm, and A. Bonci, “Orexin B/hypocretin 2 increases glutamatergic transmission to ventral tegmental area neurons,” Eur. J. Neurosci., 28, No. 8, 1545–1556 (2008).
E. S. Brazhnik and S. E. Fox, “Action potentials and relations to the theta rhythm of medial septal neurons in vivo,” Exp. Brain Res., 127, No. 3, 244–258 (1999).
G. Buszaki, “Theta oscillations in the hippocampus,” Neuron, 33, No. 3, 325–340 (2002).
A. M. Cason, R. J. Smith, P. Tahsili-Fahadan, et al., “Role of orexin/hypocretin in reward-seeking and addiction: implications for obesity,” Physiol. Behav., 100, No. 5, 419–428 (2010).
Q. Chang and P. E. Gold, “Impaired and spared cholinergic functions in the hippocampus after lesions of the medial septum/vertical limb of the diagonal band with 192 IgG-saporin,” Hippocampus, 14, No. 2, 170–179 (2004).
S. Datta, D. F. Siwek, E. H. Patterson, and P. B. Cipollini, “Localization of pontine PGO wave generation sites and their anatomical projections in the rat,” Synapse, 30, No. 4, 409–423 (1998).
A. R. Di Sebastiano, H. E. Wilson-Pérez, M. N. Lehman, and L. M. Cohen, “Lesions of orexin neurons block conditioned place preference for sexual behavior in male rats,” Horm. Behav., 59, No. 1, 1–8 (2011).
H. Dietrich and J. Jenck, “Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant,” Psychopharmacology (Berlin), 212, No. 2, 145–154 (2010).
N. Doreulee, M. Alania, M. Chikovani, et al., “Orexin-A induces long-term depression of NMDA responses in CA-1 field of hippocampal slices,” Georgian Med News, 169, 65–70 (2009).
R. P. Gaykema, J. van der Kuil, L. B. Hersh, and P. G. Luiten, “Patterns of direct projections from the hippocampus to the medial septum-diagonal band complex: anterograde tracing with Phaseolus vulgaris leucoagglutinin combined with immunohistochemistry of choline acetyltransferase,” Neuroscience, 43, No. 2–3, 349–360 (1991).
D. Gerashchenko, R. Salin-Pascual, and P. J. Shiromani, “Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal beta,” Brain Res., 913, No. 1, 106–115 (2001).
A. Gozzi, G. Turrini, L. Piccoli, et al., “Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists,” PLoS One, 6, No. 1, e16406 (2011).
A. E. Hallanger and B. H. Wainer, “Ascending projections from the pedunculopontine tegmental nucleus and the adjacent mesopontine tegmentum in the rat,” J. Comp. Neurol., 274, No. 4, 483–515 (1988).
T. Holmqvist, L. Johansson, M. Ostman, et al., “OX1 orexin receptors couple to adenylyl cyclase regulation via multiple mechanisms,” J. Biol. Chem., 280, No. 8, 6570–6579 (2005).
J. P. Kukkonen, T. Holmqvist, S. Ammoun, and K. A. Akerman, “Functions of the orexinergic/hypocretinergic system,” Am. J. Physiol. Cell. Physiol., 283, No. 6, C1567–C1591 (2002).
L. Lecourtier, A. P. de Vasconcelos, E. Leroux, et al., “Septohippocampal pathways contribute to system consolidation of a spatial memory: Sequential implication of GABAergic and cholinergic neurons,” Hippocampus, 21, No. 12, 1277–1289 (2011).
B. Li, F. Chen, J. Ye, et al., “The modulation of orexin A on HCN currents of pyramidal neurons in mouse prelimbic cortex,” Cereb. Cortex, 20, No. 7, 1756–1767 (2010).
R. J. Liu, A. N. van den Pol, and G. K. Aghajanian, “Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions,” J. Neurosci., 22, No. 21, 9453–9464 (2002).
F. Lopes da Silva, “Neural mechanisms underlying brain waves: from neural membranes to networks,” EEG Clin. Neurophysiol., 79, No. 2, 81–93 (1991).
R. G. Mair and J. R. Hembrook, “Memory enhancement with eventrelated stimulation of the rostral intralaminar thalamic nuclei,” J. Neurosci., 28, No. 52, 14293–14300 (2008).
J. N. Marcus, C. J. Aschkenasi, C. E. Lee, et al., “Differential expression of orexin receptors 1 and 2 in the rat brain,” J. Comp. Neurol., 435, No. 1, 6–25 (2001).
G. J. Morales, E. J. Ramcharan, N. Sundararaman, et al., “Analysis of the actions of nucleus reuniens and the entorhinal cortex on EEG and evoked population behavior of the hippocampus,” Conf. Proc. IEEE Eng. Med. Biol. Soc., 2480–2484 (2007).
K. Mori, J. Kim, and K. Sasaki, “Electrophysiological effects of orexin-B and dopamine on rat nucleus accumbens shell neurons in vitro,” Peptides, 32, No. 2, 246–252 (2011).
N. Nachkebia, E. Chkhartishvili, Sh. Dzadzamia, et al., “Septo-hippocampal cholinergic/GABAergic relationship and sleep-waking cycle,” Georgian Med. News, 157, 66–72 (2008).
A. Nowacka, E. Jurkowlaniec, and W. Trojniar, “Microinjection of procaine into the pedunculopontine tegmental nucleus suppresses hippocampal theta rhythm in urethane-anesthetized rats,” Brain Res. Bull., 58, No. 4, 377–384 (2002).
D. Quarta, E. Valerio, D. M. Hutcheson, et al., “The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization,” Neurochem. Int., 56, No. 1, 11–15 (2010)
P. Parra, A. J. Gulya’s, and R. Miles, “How many subtypes of inhibitory cells in the hippocampus?” Neuron, 20, No. 5, 983–993 (1998).
C. Peyron, D. K. Tighe,A. N. van den Pol, et al., “Neurons containing hypocretin (orexin) project to multiple neuronal systems,” J. Neurosci., 18, No. 23, 9996–10015 (1998).
O. Schmitt, K. G. Usunoff, N. E. Lazarov, et al., “Orexinergic innervation of the extended amygdala and basal ganglia in the rat,” Brain Struct. Funct., 217, No. 2, 233–256 (2011).
O. Selbach, C. Bohla, A. Barbara, et al., “Orexins/hypocretins control bistability of hippocampal long-term synaptic plasticity through co-activation of multiple kinases,” Acta Physiol., 198, No. 3, 277–285 (2010).
O. Selbach, N. Coreulee, C. Bohla, et al., “Orexins/hypocretins cause sharp wave- and theta-related synaptic plasticity in the hippocampus via glutamatergic, GABAergic, noradrenergic, and cholinergic signaling,” Neurosci., 127, No. 2, 519–528 (2004).
R. Sharf, M. Sarhan, and R. J. Dileone, “Orexin mediates the expression of precipitated morphine withdrawal and concurrent activation of the nucleus accumbens shell,” Biol. Psychiatry, 64, No. 3, 175–183 (2008).
J. R. Shoblock, N. Welty, L. Aluisio, et al., “Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement,” Psychopharmacology (Berlin), 215, No. 1, 191–203 (2011).
H. R. Smith and K. C. Pang, “Orexin-saporin lesions of the medial septum impair spatial memory,” Neurosci., 132, No. 2, 261–271 (2005).
J. W. Smythe, L. V. Colom, and B. H. Bland, “The extrinsic modulation of hippocampal theta depends on the coactivation of cholinergic and GABAergic medial septal inputs,” Neurosci. Biobehav. Res., 16, No. 3, 289–308 (1992).
C. H. Song, X. W. Chen, J. X. Xia, et al., “Modulatory effects of hypocretin-1/orexin-A with glutamate and gamma-aminobutyric acid on freshly isolated pyramidal neurons from the rat prefrontal cortex,” Neurosci. Lett., 399, No. 1–2, 101–105 (2006).
E. M. Stanley and J. Fadel, “Aging-related deficits in orexin/hypocretin modulation of the septo-hippocampal cholinergic system,” Synapse (2011), doi: 10.1002/syn.21533.
E. M. Stanley and J. R. Fadel, “Ageing-related alterations in orexinhypocretin modulation of septo-hippocampal amino acid neurotransmission,” Neurosci., 195, 70–79 (2011).
L. W. Swanson, “The anatomical organization of septo-hippocampal projections,” Ciba Found. Symp., 58, No. 1, 25–48 (1977).
A. J. Thorpe and C. M. Kotz, “Orexin A in the nucleus accumbens stimulates feeding and locomotor activity,” Brain Res., 1050, No. 1–2, 156–162 (2005).
K. Uramura, H. Funahashi, S. Muroya, et al., “Orexin-A activates phospholipase C- and protein kinase C-mediated Ca2+ signaling in dopamine neurons of the ventral tegmental area,” Neuroreport, 12, No. 9, 1885–1889 (2001).
O. S. Vinogradova, “Expression, control and probable functional significance of the neuronal theta rhythm,” Progr. Neurobiol., 45, No. 6, 523–583 (1995).
N. M. Vittoz and C. W. Berridge, “Hypocretin/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area,” Neuropsychopharmacology, 31, No. 2, 384–395 (2006).
M. J. Wayner, D. L. Armstrong, C. F. Phelix, and Y. Oomura, “Orexin-A (hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo,” Peptides, 25 No. 6, 991–996 (2004).
M. A. Whittington, R. D. Traub, and J. G. R. Jeffreys, “Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation,” Nature, 373, No. 6515, 612–615 (1995).
C. J. Winrow, A. L. Gotter, C. D. Cox, et al., “Promotion of sleep by suvorexant – a novel dual orexin receptor antagonist,” J. Neurogenet., 25, No. 1–2, 52–61 (2011).
M. Wu, L. Zaborszky, T. Haiszan, et al., “Hypocretin/orexin innervation and excitation of identified septohippocampal cholinergic, neurons,” J. Neurosci., 24, No. 14, 3527–3536 (2004).
M. Wu, Z. Zhang, C. Leranth, et al., “Hypocretin increases impulse flow in the septohippocampal GABAergic pathway: implications for arousal via a mechanism of hippocampal disinhibition,” J. Neurosci., 22, No. 17, 7754–7765 (2002).
J. Sia, X. Chen, C. Song, et al., “Postsynaptic excitation of prefrontal cortical pyramidal neurons by hypcretin-1/orexin A though the inhibition of potassium currents,” J. Neurosci. Res., 82, No. 5, 729–736 (2005).
G. C. Zhang, L. M. Mao, C. Y. Liu, and J. Q. Wang, “Long-lasting up-regulation of orexin receptor type 2 protein levels in the rat nucleus accumbens after chronic cocaine administration,” J. Neurochem., 103, No. 1, 4004–407 (2007).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Vysshei Nervnoi Deyatel’nosti imeni I. P. Pavlova, Vol. 62, No. 4, pp. 389–400, July–August, 2012.
Rights and permissions
About this article
Cite this article
Sil’kis, I.G. Possible Mechanisms for the Effects of Orexin on Hippocampal Functioning and Spatial Learning (analytical review). Neurosci Behav Physi 43, 1049–1057 (2013). https://doi.org/10.1007/s11055-013-9849-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-013-9849-2